Sign in Subscribe
Cancer

Epigenetic Changes in EBV-Associated Gastric Carcinoma

Strategic Insights

— 1 min read

Researchers from Sun Yat Sen University have conducted a study to evaluate the significance of epigenetic changes in Epstein-Barr virus-associated gastric carcinoma (EBVaGC). The study analyzed 49 EBVaGC tissue samples and 45 EBV-negative gastric carcinoma (EBVnGC) tissue samples, as well as cell lines, to determine the promoter methylation status and protein expression of five specific genes: p16, FHIT, CRBP1, WWOX, and DLC-1. The results showed that global genomic DNA hypomethylation was more pronounced in EBVnGC than in EBVaGC, and promoter methylation of the five genes was more frequent in EBVaGC than in EBVnGC.

Key Takeaways:

  • The study found that global genomic DNA hypomethylation was more pronounced in EBVnGC than in EBVaGC, suggesting a potential role of epigenetic changes in the development of gastric carcinoma.
  • Promoter methylation of the five genes (p16, FHIT, CRBP1, WWOX, and DLC-1) was more frequent in EBVaGC than in EBVnGC, indicating a possible distinction in gene regulation between the two types of gastric carcinoma.
  • Demethylation therapy may represent a novel therapeutic strategy for EBVaGC, as indicated by the research conclusion.
  • The study highlights the importance of considering epigenetic changes in the development and treatment of gastric carcinoma.
  • The researchers analyzed 49 EBVaGC tissue samples and 45 EBVnGC tissue samples, as well as cell lines, to support their findings.

Statistics:

  • 49 EBVaGC tissue samples were analyzed in the study.
  • 45 EBV-negative gastric carcinoma (EBVnGC) tissue samples were analyzed in the study.
  • The promoter methylation status of the five genes (p16, FHIT, CRBP1, WWOX, and DLC-1) was assessed in tissues and cell lines.
  • The study found that global genomic DNA hypomethylation was more pronounced in EBVnGC (23.33%) than in EBVaGC (14.29%).
  • Promoter methylation of the five genes was more frequent in EBVaGC (64.29%) than in EBVnGC (47.22%).

Sources:

  • Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas. Medical Oncology, 2015;32(4):41-56.
  • Medical Oncology can be contacted at: Humana Press Inc, 999 Riverview Drive Suite 208, Totowa, NJ 07512, USA.

Read more